Clinical Trial Update: A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) [Phase 4]

View source ↗

Summary

A Phase 4 trial of a new medicine to treat nonarteritic anterior ischemic optic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonarteritic Anterior Ischemic Optic Neuropathy

Snippet

Sponsor: Neuro-Ophthalmologic Associates, PC | Conditions: Non Arteritic Ischemic Optic Neuropathy | Phase 4 | Status: COMPLETED